ADAGE CAPITAL PARTNERS GP, L.L.C. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 231 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
ADAGE CAPITAL PARTNERS GP, L.L.C. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,280,000
-34.8%
400,000
-34.9%
0.04%
-34.0%
Q1 2023$23,448,660
+26.2%
614,000
+88.1%
0.05%
+20.5%
Q4 2022$18,577,850
-11.6%
326,500
-59.2%
0.04%
-17.0%
Q3 2020$21,024,000
-21.6%
800,000
-20.0%
0.05%
-23.2%
Q2 2020$26,810,000
+112.9%
1,000,000
+42.9%
0.07%
+81.6%
Q1 2020$12,593,000
-36.9%
700,000
-37.8%
0.04%
-22.4%
Q4 2019$19,946,000
+71.5%
1,125,000
+50.0%
0.05%
+69.0%
Q3 2019$11,633,000
+50.5%
750,000
+66.7%
0.03%
+52.6%
Q2 2019$7,731,000
+220.1%
450,000
+200.0%
0.02%
+216.7%
Q1 2019$2,415,000
-52.3%
150,000
-40.0%
0.01%
-45.5%
Q4 2017$5,065,000
+16.6%
250,0000.0%0.01%0.0%
Q3 2017$4,343,000
+4.2%
250,000
-23.1%
0.01%
+10.0%
Q2 2017$4,167,000
+221.5%
325,000
+225.0%
0.01%
+233.3%
Q1 2017$1,296,000
-45.6%
100,000
-46.7%
0.00%
-57.1%
Q1 2014$2,384,000187,5840.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
Bellevue Group AG 318,000$3,841,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders